Activated Protein C in Severe Sepsis

Intensive and Critical Care Nursing - United States
doi 10.1054/iccn.2001.1575
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Changes in Protein C Activity in Severe Sepsis.

Nihon Kyukyu Igakukai Zasshi
1998English

Best Evidence in Anesthetic Practice Prevention: Recombinant Human Activated Protein C Reduces Mortality in Severe Sepsis

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2002English

Surviving Ratio of Severe Sepsis Treated With Activated Protein C in One University Intensive Care Unit During 2003–2006

Critical Care
Critical CareIntensive Care Medicine
2007English

Introduction: Severe Sepsis and Drotrecogin Alfa (Activated)

Critical Care
Critical CareIntensive Care Medicine
2007English

The Clinical and Functional Relevance of Microparticles Induced by Activated Protein C Treatment in Sepsis

Critical Care
Critical CareIntensive Care Medicine
2011English

S-100β Protein in Patients With Severe Sepsis

Journal of Medical Biochemistry
BiochemistryClinical Biochemistry
2009English

Activated Protein C Action in Inflammation

British Journal of Haematology
Hematology
2010English

Drotrecogin Alfa Activated as a Treatment for Severe Sepsis in Pediatric Cancer

Bone Marrow Transplantation
TransplantationHematology
2006English

Drotrecogin Alfa (Activated) May Attenuate Severe Sepsis-Associated Encephalopathy in Clinical Septic Shock

Critical Care
Critical CareIntensive Care Medicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy